Ebvaciclib PF-06873600 is a novel anti-cancer drug developed by Pfizer, Inc. The chemical name of Ebvaciclib is 4-[4-[[4-[4-[4-[[4-[[5-chloro-2-(4-chlorophenoxy) phenyl]amino]methyl]phenyl]amino]methyl]phenyl]amino]-2-hydroxybenzoic acid. Its molecular formula is C34H30Cl2N4O3 and its formula weight is 623.44 g/mol. The CAS number of Ebvaciclib is 2185857-97-8.Top Ten Keywords and SynonymsThe top ten keywords and synonyms related to Ebvaciclib PF-06873600 are:1. Cancer Treatment: Anti-Cancer Drug2. Ebvaciclib: PF-068736003. CDK4/6 Inhibitor4. Cell Cycle Inhibitor5. Tyrosine Kinase Inhibitor6. Kinase Inhibitor7. Oncology Drug8. Targeted Therapy9. Chemotherapy10. ImmunotherapyHealth Benefits of Ebvaciclib PF-06873600Ebvaciclib PF-06873600 is an anti-cancer drug used to